Navigation Links
Stem cell research from an ethical point of view
Date:6/25/2008

Stem cell research and the potential use of human embryonic stem cells in clinical therapy is a controversial issue which splits both scientific and public opinion. The current conflict over embryonic stem cells throughout the world deals particularly with the ethical implications of this promising, but delicate subject and the scientific manipulation of human life in its early stages of development. It is a symbolic struggle over the whole future of developmental biology over how we will proceed with a wide range of research on human development. Alternative methods for gaining embryonic stem cells such as the Altered Nuclear Transfer (ANT) method developed by William B. Hurlbut, M.D., a member of The President's Council on Bioethics in Washington, D.C., are considered important steps torward embryonic stem cell research.

It is in this context that the new Springer book Stem Cells, Human Embryos and Ethics: Interdisciplinary Perspectives provides insight into this recent debate from several relevant fields. A medical and biological angle dealing with new technological possibilties in medical research and putative clinical therapy is presented as well as an ethical point of view including philosophical and theological approaches regarding the moral status of human embryos.

The various chapters of the book focus on one main problem: Is it acceptable from an ethical point of view to use stem cells from human embryos for scientific research and clinical therapy? And what are the weaknesses and strengths of various opinions and positions when they are critically evaluated? Moreover the book discusses several sub-problems strongly related to this topic, i. e. when does any individual human being begin or at what stage development does a human organism become entitled to the moral and legal protection which we give to the life of human adults?

Based on a two-year research project led by editor Lars stnor, professor of systematic theology at MF Norwegian School of Theology in Oslo, the book is a comprehensive collection of papers covering all major aspects of the ethical debate presented in an unbiased way. Instead of presenting just on opinion like many monographic books on stem cell research ethics do, the various chapters all together give a multifaceted and balanced treatment of the subject allowing readers to examine the opinions of both religious and scientific scholars side by side. The seventeen chapters of the book Stem Cells, Human Embryos and Ethics: Interdisciplinary Perspectives include updated contributions from international respected scholars such as William B. Hurlbut and Sir Anthony Kenny.

"I am of the strong opinion that the debate going on in many countries concerning stem cell research, and especially the use of human, embryonic stem cells, will profit substantially from a sufficient overview of the different aspects relevant for an ethical evaluation," said stnor as a reason for editing this book.


'/>"/>

Contact: Renate Bayaz
renate.bayaz@springer.com
49-622-148-78531
Springer
Source:Eurekalert

Related medicine news :

1. Latest Research Shows Strong Consumer Demand for Organic Foods
2. Cardiologist Praises Latest Resveratrol/Red Wine Research
3. Researchers develop neural implant that learns with the brain
4. Research Uncovers Clues to Lymphoma
5. Memory Pharmaceuticals Closes Second Tranche of Equity Financing with The Stanley Medical Research Institute
6. Leading Performance-Enhancing Drug Research Institute Anti-Doping Research (ADR) Establishes Nonprofit Status
7. Creator of PubMed Central biomedical research database recognized for outstanding citizen service
8. American Academy of Dermatology Research Shows Athletes Susceptible to Antibiotic-Resistant Staph Infections
9. Damon Runyon Cancer Research Foundation awards $2.25M to 5 top young clinical investigators
10. CIBC World Markets Equity Research Downgrades Target Price of BVF from $12.00 to a Staggering Low of $7.50 Based on Potential Incumbent Win in Proxy Battle
11. Researchers seek children for a study of antibiotics for a urinary tract disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... (PRWEB) , ... May 30, 2016 , ... ... to use inside of FCPX," said Christina Austin - CEO of Pixel Film ... for use within Final Cut Pro X. Choose from abstract transitions to more ...
(Date:5/29/2016)... ... 29, 2016 , ... Whole Health Supply is happy to announce a new ... available to the public. This is an unusual clipper because it opens to a ... , Everything about this product is concentrated on ease of use, functionality and durability. ...
(Date:5/28/2016)... ... May 28, 2016 , ... After a year and a half of planning the Multiple ... The Multiple Pathways of Recovery Conference was held May 2 -4, 2016 at the ... United Kingdom came together to explore the many pathways individuals use to get into and ...
(Date:5/27/2016)... New Hampshire (PRWEB) , ... May 27, 2016 , ... ... skin care products, announced today that it has been recognized as one of the ... entering parenthood. Badger was named as one of nine small businesses providing progressive benefits ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... educate the many who are unaware of the plight of aphasia. In collaboration ... within the “Stroke Awareness” campaign. , The link between stroke and aphasia is ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... PUNE, India , May 30, 2016 /PRNewswire/ ... research report "Healthcare Analytical Testing Services Market by ... Monitoring, Bioanalytical Services), by End User (Pharmaceutical Companies, ... published by MarketsandMarkets, The market witnessed healthy growth ... grow at a CAGR of 11.3% between 2016 ...
(Date:5/30/2016)... , May 30, 2016 Eye expert ... of premature babies to seek an eye examination ... condition     Moorfields Eye Hospital Dubai, ... London , has identified premature babies as a ... because of their particular vulnerability to retinopathy of prematurity (ROP). ROP ...
(Date:5/27/2016)... 2016 Kitov Pharmaceuticals ... on late-stage drug development, today announced the completion ... pivotal batches required for registration of KIT-302 with ... follows Kitov,s announcement in December 2015, ... its primary efficacy endpoint. "We are ...
Breaking Medicine Technology: